Ipique
Country: Եվրոպական Միություն
language: պորտուգալերեն
source: EMA (European Medicines Agency)
PAR
(PAR)
24-05-2022
documentation_request_body
documentation_request_send
documentation_request_send
active_ingredient:
bevacizumab
MAH:
Rotterdam Biologics B.V.
ATC_code:
S01LA04
INN:
bevacizumab
therapeutic_group:
Oftalmológicos
therapeutic_area:
Degeneração macular úmida
therapeutic_indication:
Treatment of neovascular (wet) age-related macular degeneration (AMD).
authorization_status:
Recusou
